Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
10/2002
10/03/2002US20020142011 Vaccine
10/03/2002US20020142008 Immunogenic pili presenting foreign peptides, their production and use
10/03/2002US20020142007 Intracellular delivery vehicles
10/03/2002US20020142006 Chimeric nontoxic mutants of enterotoxins as mucosal adjuvants for cell-mediated or humoral immunity
10/03/2002US20020142005 Immunotherapy of epithelial tumors using intralesional injection of antigens that induce a delayed type hypersensitivity reaction
10/03/2002US20020142002 Anthrax
10/03/2002US20020142001 DNA immunization against Chlaymdia infection
10/03/2002US20020142000 Genetic engineering
10/03/2002US20020141993 Apoptosis; anticancer agents
10/03/2002US20020141992 Deactivation of collagen receptors
10/03/2002US20020141991 Methods of treating inflammatory disease using antibodies which bind GPR-9-6
10/03/2002US20020141989 Antiinflammatory agents; antiallergens
10/03/2002US20020141988 Therapeutic agent for acute lung injury resulting from indirect causes comprising anti-il-8 antibody as active ingredient
10/03/2002US20020141981 Materials and methods for treating oncological disease
10/03/2002US20020141977 Immunotherapy based on dendritic cells
10/03/2002US20020141975 Alphavirus vectors and virosomes with modified HIV genes for use in vaccines
10/03/2002US20020141974 Hepatitis therapeutics
10/03/2002US20020141973 Reducing number of tumor cells
10/03/2002US20020141945 Characteristic glass transition temperature (Tg) and a recommended storage temperature (Ts), glassy matrix and drug within the glassy matrix; unit dosage; stable dispersion over time
10/03/2002US20020141941 PSCA: prostate stem cell antigen and uses thereof
10/03/2002CA2442318A1 Antibodies against cancer
10/03/2002CA2442261A1 Liposome composition for improved intracellular delivery of a therapeutic agent
10/03/2002CA2442089A1 Nucleic acid molecules encoding a transmembran serine protease 9, the encoded polypeptides and methods based thereon
10/03/2002CA2442004A1 Microbial feeds for aquaculture and agriculture
10/03/2002CA2442003A1 Methods for treating neurodegenerative diseases including alzheimer's
10/03/2002CA2441947A1 Human papilloma virus immunoreactive peptides
10/03/2002CA2441889A1 Methods for increasing analgesic potency and attenuating adverse excitatory effects of bimodally-acting opioid agonists by inhibiting gm1-ganglioside
10/03/2002CA2441809A1 Lipsomal vaccines comprising dilipopetides for modulating t1 and t2 immune responses
10/03/2002CA2441700A1 Polypeptides and nucleic acids for bolekine
10/03/2002CA2441670A1 Novel nucleic acids and polypeptides
10/03/2002CA2441663A1 Viral vectors and their use in therapeutic methods
10/03/2002CA2441588A1 Use of cytokines of the tgf-.beta. superfamily for the treatment and diagnosis of skin related disorders
10/03/2002CA2441577A1 Therapeutic agents for inflammatory bowel diseases
10/03/2002CA2441551A1 Pathogenic and commensal vaccine antigens
10/03/2002CA2441378A1 Nucleic acid molecules encoding serine protease cvsp14, the encoded polypeptides and methods based thereon
10/03/2002CA2441228A1 Combination treatment of pancreatic cancer
10/03/2002CA2440676A1 Transgenic animals expressing antibodies specific for genes of interest and uses thereof
10/03/2002CA2439961A1 Human cytokine receptor
10/03/2002CA2439678A1 Uses of opg ligand to modulate immune responses
10/03/2002CA2439431A1 Streptococcus pneumoniae proteins and nucleic acids
10/03/2002CA2438206A1 Transporters and ion channels
10/03/2002CA2436340A1 Histidine-rich glycoprotein
10/03/2002CA2436208A1 A novel virus (cryptovirus) within the rubulavirus genus and uses therefor
10/03/2002CA2425862A1 Cd19-specific redirected immune cells
10/03/2002CA2406527A1 Novel human stras-like protein and nucleic acids encoding the same
10/02/2002EP1245678A2 Recombinant proteins of viruses associated with lymphadenopathy syndrome and/or acquired immune deficiency syndrome
10/02/2002EP1245677A1 Nucleic acids and proteins of the mycoplasma hyopneumoniae mhp3 gene and uses thereof
10/02/2002EP1245676A1 Human monoclonal antibodies against tgf-beta ii receptor and medicinal use thereof
10/02/2002EP1245249A2 Use of a cationic amphipathic compound as a transfection agent, vaccine additive or drug
10/02/2002EP1245238A2 Exotoxin ligand
10/02/2002EP1244803A2 Veto cells effective in preventing graft rejection and devoid of graft versus host potential
10/02/2002EP1244793A2 Serine/threonine kinase and serine protease polypeptides and nucleic acids encoding same
10/02/2002EP1244790A2 Nucleic acids encoding polypeptides having chips activity
10/02/2002EP1244784A2 Methods and compositions for inhibiting neoplastic cell growth
10/02/2002EP1244778A2 Human heparanase-related polypeptide and nucleic acid
10/02/2002EP1244775A1 Molecular display on multimeric protein scaffolds derived from the e2 component of the alpha-ketoacid dehydrogenase
10/02/2002EP1244774A2 Pak5 a member of the p21-activated kinase (pak) protein family, nucleic acids and methods related to the same
10/02/2002EP1244773A1 Mutated hepatitis b virus, its nucleic and protein constituents and uses thereof
10/02/2002EP1244708A1 Method for treating inflammation
10/02/2002EP1244705A2 Serpentine transmembrane antigens expressed in human prostate cancers and uses thereof
10/02/2002EP1244701A1 Transferrin polynucleotides, polypeptides, and antibodies
10/02/2002EP1244697A2 Novel polypeptides and nucleic acids encoding same
10/02/2002EP1244692A2 Compositions and methods for detecting stress-inducible proteins
10/02/2002EP1244688A1 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
10/02/2002EP1244687A2 METHODS FOR PROTECTING AGAINST LETHAL INFECTION WITH i BACILLUS ANTHRACIS /i
10/02/2002EP1244684A1 Cryptosporidium sporozoite antigens
10/02/2002EP1244471A1 Liquid composition of biodegradable block copolymer for drug delivery system and process for the preparation thereof
10/02/2002EP1244470A2 Use of heat shock proteins to enhance production of chemokines by a cell
10/02/2002EP1244468A2 Selective activation of a th1 or th2 lymphocyte regulated immune response
10/02/2002EP1244466A2 Activation and inhibition of the immune system
10/02/2002EP1244356A1 Compositions and methods for l-nucleosides, l-nucleotides, and their analogs
10/02/2002EP1244350A2 Prostatic cell line and use thereof to obtain an established prostatic cancer in an animal
10/02/2002EP0841946B1 Methods for treatment of allergic asthma
10/02/2002EP0691988B1 Inhibitor of stem cell proliferation and uses thereof
10/02/2002EP0600930B1 Diagnosis and treatment of autoimmune diseases
10/02/2002CN1372598A Methods of inducing cell death
10/02/2002CN1372594A OX2 receptor homologs
10/02/2002CN1372568A Vaccin
10/02/2002CN1372567A Method for isolating and purifying grass pollen allergens
10/02/2002CN1372474A Methods for preventing or attenuating patthoangiogenic conditions
10/02/2002CN1372473A Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide
10/02/2002CN1372471A Treatment of allergic rhinitis
10/02/2002CN1372469A Immunopotentiator
10/02/2002CN1372000A Gene engineering body for somatostatin gene engineering subunit seedling
10/02/2002CN1371749A Biological therapy adjuvant originated from animal Chinese medicine
10/02/2002CN1371748A Zhonghua soft-shelled turtle aeromonad oral slow-releasing microsphere vaccinum and preparation process thereof
10/02/2002CN1371747A Anti-HIV medicine
10/02/2002CN1371690A Vaccine composition for initiating anti-N-glycolyl ganglioside immunoreaction and application thereof
10/01/2002US6460006 System for predicting compaction performance
10/01/2002US6458934 Grafted complementarity determining regions to mouse monoclonal antibodies; amino acid replacements; autoimmune disease treatment and immunosuppressants; side effect reduction
10/01/2002US6458933 Specific for hla class ii invariant chain; side effect reduction of chemotherapy; drug clearance
10/01/2002US6458925 Peptide antagonists of zonulin and methods for use of the same
10/01/2002US6458581 Carrying out in vitro the complete developmental sequence culture of protozoa in an axenic liquid culture, serum-free and buffered; contains a basic medium for insect cells and an inorganic salt, a source of amino acids and a sugar
10/01/2002US6458578 Recombinant cell line produces adenoviral gene products E1 and DEF-A, and/or DEF-B
10/01/2002US6458572 Phosphatidylglycerophosphate synthase from Staphylococcus aureus
10/01/2002US6458560 Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis
10/01/2002US6458529 Assays for promoter operability in central nervous system cells
10/01/2002US6458527 Using synthetic or recombinant polypeptides as gag antigen; diagnosis of human immunodeficiency virus
10/01/2002US6458370 Use of microparticles combined with submicron oil-in-water emulsions
10/01/2002US6458369 Composition comprising tumor cells and extracts and method of using thereof
1 ... 1306 1307 1308 1309 1310 1311 1312 1313 1314 1315 1316 1317 1318 1319 1320 1321 1322 1323 1324 1325 1326 ... 1823